IRIS
Ceribelli, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.439
AS - Asia 3.171
EU - Europa 1.210
AF - Africa 703
SA - Sud America 599
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.331
SG - Singapore 1.879
SC - Seychelles 610
CN - Cina 604
BR - Brasile 499
VN - Vietnam 292
IT - Italia 281
FI - Finlandia 203
IE - Irlanda 144
DE - Germania 122
IN - India 90
FR - Francia 88
GB - Regno Unito 87
HK - Hong Kong 85
NL - Olanda 66
CA - Canada 51
AR - Argentina 41
MX - Messico 33
SE - Svezia 30
BD - Bangladesh 29
NG - Nigeria 29
RU - Federazione Russa 28
ZA - Sudafrica 24
IQ - Iraq 23
PL - Polonia 23
MK - Macedonia 20
TR - Turchia 20
ES - Italia 19
JP - Giappone 19
EC - Ecuador 18
PK - Pakistan 18
CZ - Repubblica Ceca 15
PH - Filippine 14
ID - Indonesia 13
AE - Emirati Arabi Uniti 12
MA - Marocco 11
BE - Belgio 10
CH - Svizzera 10
CO - Colombia 10
SA - Arabia Saudita 10
UA - Ucraina 10
CL - Cile 9
GR - Grecia 8
IL - Israele 8
PE - Perù 8
TN - Tunisia 8
UZ - Uzbekistan 8
AT - Austria 7
JO - Giordania 7
AU - Australia 6
JM - Giamaica 6
KR - Corea 6
MY - Malesia 6
VE - Venezuela 6
EG - Egitto 5
LB - Libano 5
BG - Bulgaria 4
DK - Danimarca 4
DZ - Algeria 4
HN - Honduras 4
KZ - Kazakistan 4
NO - Norvegia 4
NP - Nepal 4
PY - Paraguay 4
RO - Romania 4
AL - Albania 3
KE - Kenya 3
LT - Lituania 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
EE - Estonia 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
ML - Mali 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
Totale 10.119
Salva come PNG Salva come JPEG
Città #
Singapore 800
Chandler 606
Ashburn 554
San Jose 445
Dallas 374
The Dalles 294
Shanghai 228
Helsinki 203
New York 179
Boardman 169
Beijing 162
Dublin 142
Wilmington 133
Ho Chi Minh City 115
Los Angeles 104
Hong Kong 75
Hanoi 67
Milan 60
Paris 59
San Mateo 54
Santa Clara 51
Amsterdam 45
São Paulo 38
London 36
Ann Arbor 34
Council Bluffs 33
Falkenstein 31
Benin City 27
Pune 27
Buffalo 26
Lawrence 26
Princeton 26
Leawood 23
Naples 23
Phoenix 23
Belo Horizonte 20
Brooklyn 20
Columbus 20
Warsaw 18
Chennai 17
Chicago 16
Montreal 16
Seattle 16
Stockholm 16
Woodbridge 16
Frankfurt am Main 15
Rio de Janeiro 15
Mexico City 14
Orem 14
San Francisco 14
Da Nang 13
Fairfield 13
Rome 13
Assago 12
Boston 12
Tokyo 12
Brno 11
Dhaka 11
Haiphong 11
Johannesburg 11
Toronto 11
Brasília 10
Brussels 10
Baghdad 9
Charlotte 9
Munich 9
Skopje 9
Curitiba 8
Sassari 8
Hangzhou 7
Hillsboro 7
Hyderabad 7
Quito 7
Tashkent 7
Trieste 7
Amman 6
Aurora 6
Dubai 6
Fortaleza 6
Hải Dương 6
Istanbul 6
Lima 6
Osasco 6
Pasadena 6
Porto Alegre 6
San Diego 6
Thái Bình 6
Turin 6
Zurich 6
Atlanta 5
Bitola 5
Cape Town 5
Caxias do Sul 5
Guarulhos 5
Houston 5
Jakarta 5
Jundiaí 5
Kingston 5
Kocaeli 5
Lahore 5
Totale 5.922
Salva come PNG Salva come JPEG
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 697
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 211
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 144
UTILIZZO DELLA MEPACRINA COME TERAPIA DELLE MANIFESTAZIONI CUTANEE NELLE CONNETTIVITI 143
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 132
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 129
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 123
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 118
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 117
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy 117
Lessons learned from twins in autoimmune and chronic inflammatory diseases 110
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 110
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 109
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 109
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 108
Safety issues and concerns of new immunomodulators in rheumatology 106
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 104
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 102
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 101
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 101
Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression 100
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 95
Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis 90
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma 88
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 87
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 85
PFAPA syndrome and Behçet’s disease : a comparison of two medical entities based on the clinical interviews performed by three different specialists 85
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 84
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 83
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 83
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 83
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS) 82
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 82
Disease knowledge index and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 82
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 79
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 77
Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis 77
Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies 76
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 76
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 75
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 75
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 75
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis 74
MicroRNAs in rheumatoid arthritis 72
AUTOANTIBODY TO RNA-PROTEIN COMPLEX DETECTED BY QUANTITATIVE PCR 72
A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis 71
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 71
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 70
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 70
Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways 69
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 69
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis 68
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 67
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 67
Seronegative reactive spondyloarthritis and the skin 66
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 65
Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others 65
Epigenetic Methods and Twin Studies 64
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 64
The Th17 axis in psoriatic disease : pathogenetic and therapeutic implications 64
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits 63
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 63
MicroRNAs and autoimmunity 63
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 63
Cancer in connective tissue disease 62
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 61
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine 61
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know 60
Medical cannabis and cannabinoids in rheumatology: where are we now? 60
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 60
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay 59
Elastic properties of the ascending aorta in patients with rheumatoid arthritis 59
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies 58
The interplay of epigenetics and epidemiology in autoimmune diseases: time for geoepigenetics 57
Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 57
MicroRNA-146a in autoimmunity and innate immune responses 57
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD) 57
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 56
Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies 56
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 55
Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender 55
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 55
Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study 54
Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study 54
Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients 54
Cardiological features in idiopathic inflammatory myopathies 53
The geoepidemiology of autoimmune liver disease 53
Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis 53
Unusual association between pure red cell aplasia and primary Sjögren's syndrome: a case report 53
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus 52
Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining 52
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals 52
Lupus T cells switched on by DNA hypomethylation via microRNA? 51
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 51
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases 51
Neuropsychiatric aid in children born to patients with rheumatic diseases 51
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 50
Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma 50
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis 50
Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritis 49
Totale 8.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.718
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/2022147 8 2 2 33 2 1 4 18 12 16 29 20
2022/20231.483 77 103 122 191 129 142 5 180 254 132 128 20
2023/20241.167 127 77 257 92 48 181 77 32 20 60 64 132
2024/20252.428 38 37 636 57 83 227 144 131 293 400 207 175
2025/20264.715 792 265 412 341 191 247 1.230 227 204 264 320 222
Totale 10.212